3Trepo CP. Hepatitis C vires infection in Western Europe. J Hepa- tol, 1999,31 ( Suppl 1 ) :80-83.
4Saab S, Weston SR, Ly D, et al. Comparison of the cost and effec- tiveness of two strategies for maintaining hepatitis B immuntiy in hemodialysis patients. Vaccine,2002,20 ( 25 -26 ) : 3230 -3235.
5Fores X, Ferndndez-Llama P, Pons M, et al. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant, 1997,12 (7) :736-740.
